{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:17:55Z","timestamp":1788488275738,"version":"build-2803163510"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013223","name":"PTC Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013223","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Cerebral palsy (CP) is a permanent movement or postural disorder due to non-progressive injury to the developing brain, with recent research suggesting a genetic contribution in many patients. This study aimed to investigate the genetic etiology of CP in Slovene children without a previously suspected genetic cause or with prior negative genetic testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>All children born after 2003 from the Slovenian National Registry of Cerebral Palsy (SRCP) without an established genetic diagnosis were invited to participate in this cross-sectional study. Whole exome sequencing (WES) was conducted, followed by analysis of 110 CP-associated genes. Thirteen patients underwent additional family segregation by Sanger sequencing. Genetic findings were classified according to the ACMG guidelines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study included 136 children, of whom 68 (50%) were male. Spastic CP was identified in 85% of the participants, dyskinetic in 13%, and ataxic in 2%. Gross Motor Function Classification System (GMFCS) levels varied, with the majority (36%) classified as level I. Pathogenic variants, likely pathogenic variants, or \u2018<jats:italic>de novo<\/jats:italic>\u2019 variants of unknown significance (VUS) were identified in nine children (6.6%) in <jats:italic>ATL1<\/jats:italic>, <jats:italic>CTNNB1<\/jats:italic>, <jats:italic>DYRK1<\/jats:italic>, <jats:italic>KMT2A<\/jats:italic>, <jats:italic>PROC<\/jats:italic>, <jats:italic>SPAST<\/jats:italic>, <jats:italic>ZC4H2<\/jats:italic>, and <jats:italic>ZSWIM6<\/jats:italic>. Among these nine children, two had normal brain Magnetic Resonance Imaging (MRI) and three had an unsuspicious medical history.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study identified plausible, possible, or definite genetic etiologies in a cohort of children with CP. Apart from the exclusion of individuals with a previously established genetic diagnosis, no other selection criteria were applied, allowing for an inclusive assessment of genetic contributions within this population. With the advent of personalized medicine and genetic treatment, understanding the genetic underpinnings of CP is crucial for targeted therapy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2025.1615449","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T04:13:19Z","timestamp":1753243999000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Unravelling genetic etiology of cerebral palsy: findings from a Slovenian pediatric cohort"],"prefix":"10.3389","volume":"16","author":[{"given":"Ula","family":"Arkar Silan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Treb\u0161e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jernej","family":"Kova\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihael","family":"Rogac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Troha Gergeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"\u0160ket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Bregant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borut","family":"Peterlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damjan","family":"Osredkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"15082","DOI":"10.1038\/nrdp.2015.82","article-title":"Cerebral palsy","volume":"2","author":"Graham","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1017\/S0012162201231041","article-title":"Surveillance of cerebral palsy in Europe (SCPE) reply","volume":"43","author":"Cans","year":"2001","journal-title":"Dev Med Child Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/dmcn.12865","article-title":"Decreasing prevalence in cerebral palsy: a multi-site European population-based study, 1980 to 2003","volume":"58","author":"Sellier","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/dmcn.12017","article-title":"A systematic review of risk factors for cerebral palsy in children born at term in developed countries","volume":"55","author":"McIntyre","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/dmcn.12016","article-title":"The association of cerebral palsy with birth asphyxia: a definitional quagmire","volume":"55","author":"Ellenberg","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/dmcn.13363","article-title":"The genetic basis of cerebral palsy","volume":"59","author":"Fahey","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ymgme.2021.11.001","article-title":"Cerebral palsy and related neuromotor disorders: overview of genetic and genomic studies","volume":"137","author":"Friedman","year":"2021","journal-title":"Mol Genet Metab"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/01.ogx.0000767212.46634.bb","article-title":"Molecular diagnostic yield of exome sequencing in patients with cerebral palsy","volume":"76","author":"Moreno-De-Luca","year":"2021","journal-title":"Obstet Gynecol Surv"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamapediatrics.2023.0008","article-title":"Diagnostic yield of exome sequencing in cerebral palsy and implications for genetic testing guidelines: a systematic review and Meta-analysis","volume":"177","author":"Gonzalez-Mantilla","year":"2023","journal-title":"JAMA Pediatr"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/jamaneurol.2022.3549","article-title":"Molecular diagnostic yield of exome sequencing and chromosomal microarray in cerebral palsy: a systematic review and Meta-analysis","volume":"79","author":"Srivastava","year":"2022","journal-title":"JAMA Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41582-023-00847-6","article-title":"Redefining cerebral palsies as a diverse group of neurodevelopmental disorders with genetic aetiology","volume":"19","author":"van Eyk","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/mp.2014.189","article-title":"Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy","volume":"20","author":"McMichael","year":"2015","journal-title":"Mol Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41588-024-01686-x","article-title":"Comprehensive whole-genome sequence analyses provide insights into the genomic architecture of cerebral palsy","volume":"56","author":"Fehlings","year":"2024","journal-title":"Nat Genet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1038\/s41467-021-24524-8","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons","volume":"12","author":"Pearson","year":"2021","journal-title":"Nat Commun"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ymthe.2021.11.005","article-title":"Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency","volume":"30","author":"Tai","year":"2022","journal-title":"Mol Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1212\/01.WNL.0000117981.35364.1B","article-title":"Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the quality standards Subcommittee of the American Academy of neurology and the practice Committee of the Child Neurology Society","volume":"62","author":"Ashwal","year":"2004","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1017\/s0012162200001511","article-title":"Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers","volume":"42","year":"2000","journal-title":"Dev Med Child Neurol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s12017-014-8331-9","article-title":"A diagnostic approach for cerebral palsy in the genomic era","volume":"16","author":"Lee","year":"2014","journal-title":"NeuroMolecular Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.17712\/nsj.2019.3.20190045","article-title":"Metabolic and genetic disorders mimicking cerebral palsy","volume":"24","author":"Hakami","year":"2019","journal-title":"Neurosciences"},{"key":"ref20","author":"Poplin","year":"2018"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/dmcn.14585","article-title":"Definition and diagnosis of cerebral palsy in genetic studies: a systematic review","volume":"62","author":"Pham","year":"2020","journal-title":"Dev Med Child Neurol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/s41588-020-0695-1","article-title":"Mutations disrupting neuritogenesis genes confer risk for cerebral palsy","volume":"52","author":"Jin","year":"2020","journal-title":"Nat Genet"},{"key":"ref24","year":"2025"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejpn.2019.02.001","article-title":"The genetic etiology in cerebral palsy mimics: the results from a Greek tertiary care center","volume":"23","author":"Zouvelou","year":"2019","journal-title":"Eur J Paediatr Neurol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/acn3.551","article-title":"Genomic analysis identifies masqueraders of full-term cerebral palsy","volume":"5","author":"Takezawa","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1212\/WNL.0000000000001494","article-title":"Copy number variations in cryptogenic cerebral palsy","volume":"84","author":"Segel","year":"2015","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1001\/archneur.61.5.637","article-title":"Genetic basis of developmental malformations of the cerebral cortex","volume":"61","author":"Mochida","year":"2004","journal-title":"Arch Neurol"},{"key":"ref29","year":"2025"},{"key":"ref30","author":"Stevanin","year":"2021"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3988\/jcn.2023.0500","article-title":"Genetic diagnosis in neonatal encephalopathy with hypoxic brain damage using targeted gene panel sequencing","volume":"20","author":"Lee","year":"2024","journal-title":"J Clin Neurol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/cge.14522","article-title":"Clinical exome sequencing uncovers genetic disorders in neonates with suspected hypoxic\u2013ischemic encephalopathy: a retrospective analysis","volume":"106","author":"Parobek","year":"2024","journal-title":"Clin Genet"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/08830738221147805","article-title":"Identifying genetic susceptibility in neonates with hypoxic-ischemic encephalopathy: a retrospective case series","volume":"38","author":"Woodward","year":"2023","journal-title":"J Child Neurol"},{"key":"ref34","year":"2017"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/0883073819840449","article-title":"Genetic or other causation should not change the clinical diagnosis of cerebral palsy","volume":"34","author":"MacLennan","year":"2019","journal-title":"J Child Neurol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/brain\/awy331","article-title":"Gene therapy improves motor and mental function of aromatic l-amino acid decarboxylase deficiency","volume":"142","author":"Kojima","year":"2019","journal-title":"Brain"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms232012564","article-title":"Correlation between phenotype and genotype in CTNNB1 syndrome: a systematic review of the literature","volume":"23","author":"Miro\u0161evi\u010d","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref38","year":"2019"},{"key":"ref39","author":"Osredkar","year":"2022"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"768023","DOI":"10.3389\/fphar.2021.768023","article-title":"Current drug repurposing strategies for rare neurodegenerative disorders","volume":"12","author":"Shah","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/dmcn.13166","article-title":"MRI classification system (MRICS) for children with cerebral palsy: development, reliability, and recommendations","volume":"59","author":"Himmelmann","year":"2017","journal-title":"Dev Med Child Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1615449\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T04:13:20Z","timestamp":1753244000000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1615449\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":41,"alternative-id":["10.3389\/fneur.2025.1615449"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1615449","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"article-number":"1615449"}}